Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Abstract

Patients with severely decreased glomerular filtration rate (GFR) (i.e., chronic kidney disease [CKD] G4+) are at increased risk for kidney failure, cardiovascular disease (CVD) events (including heart failure), and death. However, little is known about the variability of outcomes and optimal therapeutic strategies, including initiation of kidney replacement therapy (KRT). Kidney Disease: Improving Global Outcomes (KDIGO) organized a Controversies Conference with an international expert group in December 2016 to address this gap in knowledge. In collaboration with the CKD Prognosis Consortium (CKD-PC) a global meta-analysis of cohort studies (n = 264,515 individuals with CKD G4+) was conducted to better understand the timing of clinical outcomes in patients with CKD G4+ and risk factors for different outcomes. The results confirmed the prognostic value of traditional CVD risk factors in individuals with severely decreased GFR, although the risk estimates vary for kidney and CVD outcomes. A 2- and 4-year model of the probability and timing of kidney failure requiring KRT was also developed. The implications of these findings for patient management were discussed in the context of published evidence under 4 key themes: management of CKD G4+, diagnostic and therapeutic challenges of heart failure, shared decision-making, and optimization of clinical trials in CKD G4+ patients. Participants concluded that variable prognosis of patients with advanced CKD mandates individualized, risk-based management, factoring in competing risks and patient preferences.

Continuous renal replacement therapy in Iran; current practice, indications and outcomes in hemodynamically unstable patients

“…Previous studies have asserted a direct correlation between pre-admission creatinine level and mortality rate in patients undergoing CRRT (38,39). However, neither pre-dialysis nor post-dialysis serum creatinine levels were significantly associated with mortality rate in this study.…”

Cost‐analysis of persistent hyperkalaemia in non‐dialysis chronic kidney disease patients under nephrology care in Italy

“…In particular, retarding dialysis start is a major clinical and economical goal of Nephrology care. The international expert panel of Kidney Disease: Improving Global Outcomes (KDIGO) Guidelines has repeatedly brought to attention of nephrology community the importance of conservative care as rational treatment alternative to dialysis even in advanced CKD because dialysis initiation associates with a still dramatically increase in mortality, poorer quality of life in survivors, and striking hike of economic costs …”

Patient-reported outcome measures as a new application in the Swedish Renal Registry: health-related quality of life through RAND-36

“…Interventions aimed at giving feedback and discussing the HRQoL outcomes face-to-face with the individual patient have been studied within oncology and diabetes care [ 2 , 3 ]. Person-centered care and patient partnership have been increasingly highlighted as an important factor in improving health care quality [ 4 ]. Patient-reported outcome measures (PROMs) have the potential to be a useful tool in achieving this.…”